Keynote Address: From Reading The Genome For Risk To Rewriting It For Cardiovascular Health
(GMT-05:00) Eastern Time (US & Canada)45 minutes
Speakers
Sekar Kathiresan, M.D. - Co-Founder and CEO, Verve Therapeutics
Tracks
| Name | Audience |
|---|---|
| Conference Wide |